Literature DB >> 7468062

Effect of low-dose heparin and dihydroergotamine on frequency of postoperative deep-vein thrombosis in patients undergoing post-traumatic hip surgery.

G Lahnborg.   

Abstract

The effect of low doses of heparin (5000 units of sodium heparin every 12 hours for 10 days) and dihydroergotamine (DHE) (0.5 mg at the same intervals as heparin) on the incidence of deep-vein thrombosis (D.V.T.) in the legs was studied on 210 patients undergoing nailing of a fractured neck of the femur. The patients were allocated randomly to receive heparin (70 patients) or heparin + dihydroergotamine (71 patients) or saline (69 patients, acting as controls). D.V.T. developed in 15 patients in the heparin group, in 12 patients in heparin + DHE group and in 28 patients in the control group. There is a significant difference between the two groups receiving heparin on the one hand and the control group on the other. DHE does not seem to reduce the incidence of D.V.T. any further in this group of patients.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7468062

Source DB:  PubMed          Journal:  Acta Chir Scand        ISSN: 0001-5482


  8 in total

1.  [Different effectiveness of two preparations of low molecular weight heparin in patients with elective hip joint replacement].

Authors:  U Weber; K Koppenhagen; H Mälzer; M Matthes
Journal:  Langenbecks Arch Chir       Date:  1991

2.  Prevention of thromboembolism in hip-fracture patients. Comparison of low-dose heparin and low-molecular-weight heparin combined with dihydroergotamine.

Authors:  M R Lassen; L C Borris; H M Christiansen; F Møller-Larsen; V E Knudsen; P Boris; A M Nehen; A G Jurik; A de Carvalho; B W Nielsen
Journal:  Arch Orthop Trauma Surg       Date:  1989       Impact factor: 3.067

Review 3.  Physiological changes due to age. Implications for the prevention and treatment of thrombosis in older patients.

Authors:  M T Nurmohamed; H R Büller; J W ten Cate
Journal:  Drugs Aging       Date:  1994-07       Impact factor: 3.923

4.  [Prevention of thromboembolism in para-articular femoral fractures of the hip--results of a prospective randomized study of heparin-DHE and ASS-DHE].

Authors:  E Orthner; H Hertz; O Kwasny; R Maier; F Zekert; M Schemper; R Höfer; H Bergmann; E Havlick; F X Wohlzogen
Journal:  Unfallchirurgie       Date:  1990-06

5.  Prevention of deep vein thrombosis in patients with hip fractures: low molecular weight heparin versus dextran.

Authors:  D Oertli; P Hess; M Durig; U Laffer; R Fridrich; K Jaeger; R Kaufmann; F Harder
Journal:  World J Surg       Date:  1992 Sep-Oct       Impact factor: 3.352

Review 6.  [Thrombosis prevention with heparin/dihydroergotamine versus heparin/Sintrom in Ender nailing of pertrochanteric fractures].

Authors:  G Schlag; T Gaudernak; H Pelinka; H Redl; H Kuderna; J Poigenfürst
Journal:  Unfallchirurgie       Date:  1988-02

7.  [Thromboembolism prevention in surgical medicine: heparin or heparin-dihydroergotamine?].

Authors:  H Rasche; J Vollmar; C Burri; H G Beger; J Kilian; J Kinzl; W Krautzberger; C Wenzke
Journal:  Langenbecks Arch Chir       Date:  1983

Review 8.  Rational antithrombotic therapy and prophylaxis in elderly, immobile patients.

Authors:  E C van Gorp; D P Brandjes; J W ten Cate
Journal:  Drugs Aging       Date:  1998-08       Impact factor: 4.271

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.